Literature DB >> 1711412

The presence of alpha 2u-globulin is necessary for d-limonene promotion of male rat kidney tumors.

D R Dietrich1, J A Swenberg.   

Abstract

In a 2-year carcinogenesis bioassay, d-limonene (dL) induced kidney tumors in male F344 rats, but not in female F344 rats or either sex of mice, d-Limonene-1,2-oxide, a metabolite of dL, has been shown to bind reversibly the male rat-specific urinary protein, alpha2u-globulin (alpha 2u-G), lysosomal degradation than alpha 2u-G alone. This reduced degradation of alpha 2u-G-chemical complex leads to an accumulation of this protein in the proximal convoluted tubules of the male rat kidney and to the morphological changes characteristic for alpha 2u-globulin nephropathy. The only male rat strain known to be resistant to this renal disease is the alpha 2u-G deficient NCI-Black-Reiter (NBR) rat. The objectives of this study were to determine whether or not dL causes sustained increases in cell proliferation and has promoting activity for renal adenomas in male rats and if the male rat-specific urinary protein, alpha 2u-G, is required. In a 32-week initiation-promotion assay, male F344 and NBR rats were treated with either 0 or 500 ppm N-ethyl-N-hydroxyethylnitrosamine (EHEN) in the drinking water for 2 weeks. Experimental groups of 31 to 38 rats then received 0 or 150 mg d-limonene/kg/day in corn oil for 30 weeks by p.o. gavage 5 days/week. Cell proliferation in the proximal tubules was assessed via 5-bromo-2'-deoxyuridine-filled osmotic mini-pumps and immunohistochemistry after 7 weeks (2 weeks EHEN + 5 weeks dL) and at the end of the study (2 weeks EHEN + 30 weeks dL). Preneoplastic and neoplastic lesions were quantified in perfusion-fixed kidneys. A 5-fold increase in the labeling index of P2-cells was found after 5 weeks and 30 weeks of promotion in all dL-treated F344 rats, whereas no difference between treatment groups was detected in NBR rats. No increase in tumors or preneoplastic lesions was detected in dL-treated NBR rats, whereas a 10-fold increase in renal adenomas and atypical hyperplasias was found in the EHEN-dL-treated F344 rats compared with F344 rats treated with EHEN-corn oil. d-Limonene treatment alone caused a significant increase in the number of atypical tubules and atypical hyperplasias in F344 rats when compared with the F344 vehicle control. On the other hand, a significantly lower incidence of liver tumors was found in EHEN-dL-treated F344 rats compared with F344 rats treated with EHEN-corn oil, suggesting a chemopreventative effect of dL on EHEN-induced liver carcinogenesis in F344 rats.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1711412

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  20 in total

1.  Renal Cell Carcinomas in Vinylidene Chloride-exposed Male B6C3F1 Mice Are Characterized by Oxidative Stress and TP53 Pathway Dysregulation.

Authors:  Schantel A Hayes; Arun R Pandiri; Thai-vu T Ton; Hue-Hua L Hong; Natasha P Clayton; Keith R Shockley; Shyamal D Peddada; Kevin Gerrish; Michael Wyde; Robert C Sills; Mark J Hoenerhoff
Journal:  Toxicol Pathol       Date:  2015-12-17       Impact factor: 1.902

2.  Diethylnitrosamine- and partial hepatectomy-induced decrease in alpha 2u-globulin mRNA level in the rat liver.

Authors:  K Matuoka; I Markus; A Wong; G J Smith
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

3.  Correlation of individual papilloma latency time with DNA adducts, 8-hydroxy-2'-deoxyguanosine, and the rate of DNA synthesis in the epidermis of mice treated with 7,12-dimethylbenz[alpha]anthracene.

Authors:  W H Fischer; W K Lutz
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

4.  A possible role for cell proliferation in potassium bromate (KBrO3) carcinogenesis.

Authors:  T Umemura; K Sai; A Takagi; R Hasegawa; Y Kurokawa
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

5.  Biodegradable, effective substitute for xylene in the Ehrlich indole procedure.

Authors:  J M Miller; M D Miller; P E Driscoll; P Miller
Journal:  J Clin Microbiol       Date:  1994-08       Impact factor: 5.948

6.  Human metabolism of the experimental cancer therapeutic agent d-limonene.

Authors:  P L Crowell; C E Elson; H H Bailey; A Elegbede; J D Haag; M N Gould
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

7.  Compensatory regeneration as a mechanism for renal tubule carcinogenesis of fumonisin B1 in the F344/N/Nctr BR rat.

Authors:  P C Howard; A Warbritton; K A Voss; R J Lorentzen; J D Thurman; R M Kovach; T J Bucci
Journal:  Environ Health Perspect       Date:  2001-05       Impact factor: 9.031

Review 8.  Implications for risk assessment of suggested nongenotoxic mechanisms of chemical carcinogenesis.

Authors:  R L Melnick; M C Kohn; C J Portier
Journal:  Environ Health Perspect       Date:  1996-03       Impact factor: 9.031

9.  Cell Proliferation and Chemical Carcinogenesis: summary and future directions.

Authors:  J A Swenberg
Journal:  Environ Health Perspect       Date:  1993-12       Impact factor: 9.031

Review 10.  Cell proliferation and renal carcinogenesis.

Authors:  B G Short
Journal:  Environ Health Perspect       Date:  1993-12       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.